Product Program year 2025 Source: CMS Open Payments

General - Pulmonary

Device General - Pulmonary_ENDO

Open in the dashboard

General payments

$145,674

320 payments

Research payments

$0

0 payments

Through program year 2025, $145,674 in general payments and $0 in research payments were reported against General - Pulmonary (General - Pulmonary_ENDO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $919 15
2022 General $121,294 290
2021 General $23,461 15

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $145,674 320 payments
Top recipients General payments · program year 2025
  1. Adnan Majid Pulmonary Disease · Boston, MA $107 12% · 1 payment
  2. Mihir Parikh Internal Medicine · Boston, MA $107 12% · 1 payment
  3. Jason Beattie Pulmonary Disease · Boston, MA $107 12% · 1 payment
  4. Kai Swenson Pulmonary Disease · Boston, MA $107 12% · 1 payment
  5. Ayman Abdul Ghani Thoracic Surgery (Cardiothoracic Vascular Surgery) · Honolulu, HI $85 9% · 1 payment

The top 5 of 15 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $459 53% · 6 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $162 19% · 2 practitioners
  3. Internal Medicine $107 12% · 1 practitioner
  4. Critical Care Medicine Internal Medicine $85 10% · 1 practitioner
  5. Gastroenterology Internal Medicine $28 3% · 2 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $429 47% · 4 recipients
  2. Hawaii $255 28% · 3 recipients
  3. Texas $158 17% · 7 recipients
  4. Arkansas $77 8% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

320 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record